FOLH1 and prostate cancer: This observation is supported by a work of Schmidkonz et al. who could show the utility of [68Ga]Ga-PSMA-11 PET/CT-derived quantitative volumetric tumor parameters for classification and determination of response to therapy of bone metastases in comparison with fully diagnostic conventional CT in patients with metastasized prostate cancer 24.